Additive Bronchoprotective and Bronchodilator Effects With Single Doses of Salmeterol and Montelukast in Asthmatic Patients Receiving Inhaled Corticosteroids
Authors:
- Andrew M. WilsonAWAndrew M. Wilson
- Erika J. SimsESErika J. Sims
- Catrina MistryCMCatrina Mistry
- Brian J. LipworthBLBrian J. Lipworth
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Differential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Fortnightly review: Modern drug treatment of chronic asthmaBMJ, 1999
- A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterolJournal of Allergy and Clinical Immunology, 1999
- Leukotriene-receptor antagonistsThe Lancet, 1999
- Anti-inflammatory effect of β2-agonists: Inhibition of TNF-α release from human mast cellsJournal of Allergy and Clinical Immunology, 1997
- Comparison of Salmeterol and Albuterol-induced Bronchoprotection Against Adenosine Monophosphate and Histamine in Mild AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma?Thorax, 1997
- Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patientsThorax, 1997
- Salmeterol tachyphylaxis in steroid treated asthmatic subjects.Thorax, 1996
- Greater Effect of Inhaled Budesonide on Adenosine 5′-Monophosphate-induced than on Sodium-Metabisulfite-induced Bronchoconstriction in AsthmaAmerican Review of Respiratory Disease, 1992